Skip to content

Legal status · United States

Is Mitoglitazone legal in the United States?

Written by Reviewed Sep 2026

Not approvedLongevityStudies in people cited: 4

Direct answer

No. Mitoglitazone is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 2 completed human trials are cited on its profile.

People given it
385
Found nothing
1

Legal category

Investigational, not approved

FDA approval and compounding status, from the Mitoglitazone profile.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Mitoglitazone in the United States at a glance

Legal categoryInvestigational, not approved
FDA approval statusInvestigational, not approved. Mid-stage studies in type 2 diabetes (2011) and Alzheimer disease (2013) finished, with results posted. No final-stage study registered. The longer lifespan was in male mice started on it at 7 months old. A repeat test started at 18 months found no benefit in males and shorter lives in females.
Studies in people4 of 8 sources on the profile
ReviewedSep 2026

The legal category and note come from the Mitoglitazone profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.

What this means

  • 01

    Mitoglitazone is being tested in registered clinical trials (official studies in people). FDA has not approved it for sale in the United States.

  • 02

    The only legal ways for a person to get it are to join a trial, or to use an official early-access program where one exists. There is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial supplies. That label does not make them legal to use in people.

What Mitoglitazone is

In people, it was tested in 356 people with type 2 diabetes and 29 people with Alzheimer disease. The company ran both studies, and no large final-stage study followed. In male mice started at 7 months, typical lifespan rose 8.7 percent. A retest started at 18 months failed, and female mice died sooner.

Mitoglitazone is a diabetes drug from the same family as pioglitazone. It was built to keep pioglitazone's effect on insulin while avoiding its main downsides, water retention and weight gain.

How it works: Mitoglitazone sticks to the pyruvate carrier, a two-part gate (MPC1 and MPC2) that lets pyruvate into mitochondria. A lab method that chemically tags what a drug touches found this gate is where drugs in this family bind inside mitochondria.

Approval history: Investigational, not approved. Mid-stage studies in type 2 diabetes (2011) and Alzheimer disease (2013) finished, with results posted. No final-stage study registered. The longer lifespan was in male mice started on it at 7 months old. A repeat test started at 18 months found no benefit in males and shorter lives in females.

How FDA treats this kind of product

Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.

The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Mitoglitazone on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check FDA directly

Mitoglitazone in sport and the military

Whether Mitoglitazone is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Mitoglitazone by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Mitoglitazone in other countries

Frequently asked questions

Is Mitoglitazone legal in the United States?

No. Mitoglitazone is not approved for any medical use in the United States. Its legal category is "Investigational, not approved". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 2 completed human trials are cited on its profile.

Can I buy Mitoglitazone in the United States?

There is no approved product to buy. In the United States, Mitoglitazone has the legal category "Investigational, not approved". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.

Is Mitoglitazone FDA approved?

No. FDA status: Investigational, not approved. Mid-stage studies in type 2 diabetes (2011) and Alzheimer disease (2013) finished, with results posted. No final-stage study registered. The longer lifespan was in male mice started on it at 7 months old. A repeat test started at 18 months found no benefit in males and shorter lives in females.. Current US legal category: "Investigational, not approved". On the evidence, 2 completed human trials are cited on its profile.

Related compounds in the United States

Full research profile

How Mitoglitazone works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Mitoglitazone profile

This page is general information about the legal status of Mitoglitazone in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.